Custom Search

William Stimson of Scotland

Friday 11th April 2008
Professor William Stimson

NextGen Bioscience, Inc has appointed William Stimson of Scotland to its International Scientific Advisory Board. Even more admirable, they have a picture of a livewire sufficiently notable to be entitled "William Stimson of Scotland" though a Google search will not quickly retrieve his image in a general search. But judging from an education through the Universities of St Andrews, Dundee and Glasgow he

 Professor William Stimson BSc. PhD. CBiol. FIBiol. FioN. FWIF. FRSE
holds the Chair of Immunology, division of Immunology, microbiology
and biochemistry, at Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde (since 1981).

Trained as a biochemist at the University of St Andrews (BSc Hon, 1st, 1968 and PhD, 1971). Moved to a postdoctoral Fellowship in the Department of Obstetrics and Gynaecology, University of Dundee, and then to Glasgow. He formed the division of Immunology in 1984, which then became the department of Immunology in 1991. The department attained a 5* rating in the 1996 Research Assessment Exercise.
 
Professor Stimson is holder of the 1982 City of Glasgow ‘Loving Cup,'  chairman of the Institute of Nanotechnology and the Nanomedicine
Committee and intimately involved in the formation of 8 companies and presently sits on the boards of five.

He has supervised 35 PhD and 7 MPhil students and published more than 200 scientific papers and 12 patents. He has been Intimately involved in the formation of 8 university ‘spin-out’ companies and consultant to 5 multinationals on a long term basis (incl. Akzo Nobel – 19 years, Rhone Poulenc – 13 years). He has been a director of Viragen.

Collaborative work with the Oncology departments at the University of Nottingham and the Memorial Sloan Kettering Cancer Center, New York, has lead to the production of 2 therapeutic antibodies.

Both of these had been used in cancer treatment before but induced a significant human anti-mouse response. These have subsequently been modified to address this shortcoming and have been shown to retain all effector functions required for therapeutic efficacy.

Source: http://www.nextgenbioscience.com/management/index.htm

 

 

 

 

 

 

 

 

 

                                                                            The Glasgow Loving Cup

Scotland, Computer News in Scotland, Technology News in Scotland, Computing in Scotland, Web news in Scotland computers, Internet, Communications, advances in communications, communications in Scotland, Energy, Scottish energy, Materials, Biomedicine, Biomedicine in Scotland, articles in Biomedicine, Scottish business, business news in Scotland.

Website : beachshore